Company news
Traws Pharma, Inc. news in 2022
Traws Pharma, Inc.'s news releases, calls and decks from 2022, newest first.
Onconova Therapeutics Appoints Drs. Peter Atadja and Trafford Clarke to its Board of Directors
December 18, 2022
Onconova Therapeutics to Present at the Upcoming MedInvest Oncology Investor Conference
December 6, 2022
Onconova Therapeutics to Present at the Upcoming RHK Capital Disruptive Growth Conference
November 27, 2022
Onconova Therapeutics Announces Plans for a Phase 1/2a Trial of Narazaciclib Combined with Letrozole in Endometrial Cancer, Reports Third Quarter 2022 Financial Results, and Provides a Business Update
November 13, 2022
Onconova Therapeutics to Provide Corporate Update and Announce Third Quarter Financial Results on November 14, 2022
November 6, 2022
Onconova Therapeutics to Present at the H.C. Wainwright 24th Annual Global Investment Conference
August 31, 2022
Onconova Therapeutics Reports Second Quarter 2022 Financial Results and Provides Business Update
August 10, 2022
Onconova Therapeutics Reports First Quarter 2022 Financial Results and Provides Business Update
May 10, 2022